Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
03/10/1999 | EP0900849A1 Receptor-mediated gene transfer system for targeting tumor gene therapy |
03/10/1999 | EP0900848A2 MecB polynucleotides and polypeptides from the Clpc ATPase family of Stapyloccoccus aureus |
03/10/1999 | EP0900847A2 Phosphoribosyl transferase from Staphylococcus aureus |
03/10/1999 | EP0900846A2 Nucleic acid encoding Streptococcus pneumoniae response regulator |
03/10/1999 | EP0900845A2 Signal recognition particle polypeptides and polynucleotides |
03/10/1999 | EP0900844A2 Membrane protein of Staphylococcus aureus |
03/10/1999 | EP0900843A2 FfH polypeptide from Streptococcus |
03/10/1999 | EP0900824A1 4-Hydroxyquinoline-3-carboxylic acid derivatives as light stabilizers |
03/10/1999 | EP0900799A1 Novel atropisomers of 2,3-disubstituted-(5,6)-heteroarylfused-pyrimidin-4-ones |
03/10/1999 | EP0900797A1 1-methylcarbapenem derivatives |
03/10/1999 | EP0900796A1 Preventives and remedies for ischemic intestinal lesion and ileus |
03/10/1999 | EP0900793A1 Cycloalkylaminomethylpyrrolidine derivatives |
03/10/1999 | EP0900789A2 Substituted quinolone derivatives and pharmaceuticals containing the same |
03/10/1999 | EP0900781A2 Phenolic acid amides of hydroxy substituted benzylamines |
03/10/1999 | EP0900582A1 Method for removal of residual organic solvents from a crystalline bulk substance and use thereof in manufacturing pharmaceuticals |
03/10/1999 | EP0900568A2 AMPA antagonists for the treatment of dyskinesias associated with dopamine agonist therapy |
03/10/1999 | EP0900567A2 Quinazoline-4-one AMPA antagonists for the treatment of dyskinesias associated with dopamine agonist therapy |
03/10/1999 | EP0900565A1 Patch containing isosorbide dinitrate |
03/10/1999 | EP0900564A1 Long-acting antiseptic vaginal tablet |
03/10/1999 | EP0900562A1 Lavage solution for intestinal tract |
03/10/1999 | EP0900384A2 Novel treatment |
03/10/1999 | EP0900371A1 Systems and methods for quantifying photoreactions in light activated materials |
03/10/1999 | EP0900280A2 Use of a polypeptide as cell receptor for adenoviruses |
03/10/1999 | EP0900275A1 Methods and reagents for modulating apoptosis |
03/10/1999 | EP0900272A2 Tumor necrosis factor alpha convertase |
03/10/1999 | EP0900235A1 Fragments of cr1 and their use |
03/10/1999 | EP0900234A1 21-substituted progesterone derivatives as new antiprogestational agents |
03/10/1999 | EP0900233A1 Novel steroid nitrite and nitrate ester derivatives useful as anti-inflammatory drugs |
03/10/1999 | EP0900231A1 Flea protease proteins, nucleic acid molecules, and uses thereof |
03/10/1999 | EP0900225A1 Alkyl-4-silyl-phenols and esters thereof as antiatherosclerotic agents |
03/10/1999 | EP0900223A1 Thienopyridine derivatives and their use |
03/10/1999 | EP0900221A1 Spiroazabicyclic compounds, processes for their preparation, and their pharmaceutical use |
03/10/1999 | EP0900219A1 Heterocyclic compounds |
03/10/1999 | EP0900218A1 Heterocyclic compounds |
03/10/1999 | EP0900217A1 Heterocyclic compounds |
03/10/1999 | EP0900215A1 N-3 substituted pyrimidin-4-ones with aii antagonistic activity |
03/10/1999 | EP0900212A1 Chiral phenyldihydrofuranones as pde-iv inhibitors |
03/10/1999 | EP0900211A1 Thiadiazolyl(thio)ureas useful as matrix metalloprotease inhibitors |
03/10/1999 | EP0900210A1 Antivirally active heterocyclic azahexane derivatives |
03/10/1999 | EP0900209A1 Thiazoline acid derivatives |
03/10/1999 | EP0900207A1 Pyrazinone thrombin inhibitors |
03/10/1999 | EP0900204A1 Heterocyclic compounds |
03/10/1999 | EP0900203A1 Quinoline derivatives, processes for their preparation, and their use as medicaments |
03/10/1999 | EP0900202A1 3-alkoxypyridine-2-carboxylic acid amide esters, their preparation and their use as drugs |
03/10/1999 | EP0900201A1 Pyridinyl-2-cyclopenten-1-ones as selective cyclooxygenase-2 inhibitors |
03/10/1999 | EP0900200A1 Pharmaceutical compositions for prevention and treatment of central nervous system disorders |
03/10/1999 | EP0900199A1 Azetidinone derivatives for the treatment of atherosclerosis |
03/10/1999 | EP0900198A1 New vitamin d derivatives with carbo- or heterocyclic substituents at c-25, a process for their production, intermediate products and their use for producing medicaments |
03/10/1999 | EP0900197A1 Beta-thiopropionyl-aminoacid derivatives and their use as beta-lactamase inhibitors |
03/10/1999 | EP0900185A1 Vitamin d analogs and methods of preparing these compounds |
03/10/1999 | EP0900089A1 Biological material free of viral and molecular pathogens and a process for the production thereof |
03/10/1999 | EP0900088A2 Inclusion complexes of aryl-heterocyclic salts |
03/10/1999 | EP0900086A1 Enhancement of sleep with a growth hormone secretagogue |
03/10/1999 | EP0900085A1 Method for treating excessive aggression |
03/10/1999 | EP0900084A1 Use of panaverium bromide for preventing cell proliferation and diseases caused thereby in the liver and digestive tract |
03/10/1999 | EP0900083A1 Novel substituted imidazole compounds |
03/10/1999 | EP0900082A1 Pyridyl- and pyrimidyl-piperazines in the treatment of substance abuse disorders |
03/10/1999 | EP0900081A1 Inhibitors of farnesyl-protein transferase |
03/10/1999 | EP0900080A1 Novel indole and benzothiazole derivatives |
03/10/1999 | EP0900079A1 Use of 3-amino-4-hydroxybenzoic acid for the treatment of retroviral infections |
03/10/1999 | EP0900078A1 Use of benzonaphthalene derivatives to make medicaments for treating diseases of the central nervous system |
03/10/1999 | EP0900077A1 Serum cholesterol lowering agent |
03/10/1999 | EP0900076A1 Transdermal device |
03/10/1999 | EP0817624A4 Inhibitors of metazoan parasite proteases |
03/10/1999 | EP0785769B1 Therapeutic vitamin-calcium combination in unitary galenic tablet form, method for preparing same and use thereof |
03/10/1999 | EP0773951B1 Dinucleoside-5',5'-pyrophosphates |
03/10/1999 | EP0733049B1 Tricyclic derivatives and their use in pharmaceuticals |
03/10/1999 | EP0714386B1 Water-soluble nimesulide salt, and uses thereof for the treatment of inflammations |
03/10/1999 | EP0708785B1 Heparin derivatives having antimetastatic activity |
03/10/1999 | EP0681590B1 Anticoagulant composition |
03/10/1999 | EP0677039B1 Cyclobutane derivatives as inhibitors of squalene synthetase and protein farnesyltransferase |
03/10/1999 | EP0649425B1 Pyridino-, pyrrolidino- and azepino-substituted oximes useful as anti-atherosclerosis and anti-hypercholesterolemic agents |
03/10/1999 | EP0623137B1 Antiparasitic agents |
03/10/1999 | EP0505400B1 N-substituted naphthalamides, their production and use |
03/10/1999 | CN1210558A Recombinant phages |
03/10/1999 | CN1210540A Triazole derivatives useful in therapy |
03/10/1999 | CN1210539A Cephem compounds and pharmaceutical use thereof |
03/10/1999 | CN1210538A Condensed 2,3-benzodiazepine derivatives and their use as ampa-receptor inhibitors |
03/10/1999 | CN1210535A Taxane derivatives having pyridil substituted C13 side chain, their preparation and their use as anti-tumor agents |
03/10/1999 | CN1210534A Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
03/10/1999 | CN1210532A Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
03/10/1999 | CN1210531A Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
03/10/1999 | CN1210530A Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
03/10/1999 | CN1210529A Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
03/10/1999 | CN1210528A Dihydrobenzofuran compounds useful as anti-inflammatory agents |
03/10/1999 | CN1210527A Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
03/10/1999 | CN1210525A Taxoids, preparation thereof and pharmaceutical compositions containing same |
03/10/1999 | CN1210521A Isoquinoline derivatives and drugs |
03/10/1999 | CN1210517A Hydroxamic acid derivatives for use with treatment of diseases related to connective tissue degradation |
03/10/1999 | CN1210469A Mixtures derived from eugenia jambolana lamarck, preparation and use of said mixtures and some of their constituents as medicaments |
03/10/1999 | CN1210467A Formulation |
03/10/1999 | CN1210466A Colonic delivery of nicotine to treat inflammatory bowel disease |
03/10/1999 | CN1210465A Method of treatment and pharmaceutical composition |
03/10/1999 | CN1210464A Aqueous formulation comprising bambuterol and use thereof |
03/10/1999 | CN1210463A Transparent aqueous solution of diclofenac sodium and medicinal compositions with the use of the same |
03/10/1999 | CN1210462A External preparation containing tranilast and process for producing the same |
03/10/1999 | CN1210461A Traitement and prevention of adverse effects of reactive oxygen species |
03/10/1999 | CN1210105A Process for preparation of 2,5-disubstituted pyridines |
03/10/1999 | CN1210010A Process for preparing oral liquor of poria polysaccharide |
03/10/1999 | CN1209996A Medicinal composition containing ginsenoside Re, preparation and usage thereof |